1ST.AX rises 22.22% to A$0.011 ASX pre-market 05 Feb 2026: volume surge signals outlook

The 1ST.AX stock moved sharply in ASX pre-market trade on 05 Feb 2026, rising 22.22% to A$0.011 on a volume spike of 2,075,140 shares. This jump follows above-average trading and leaves the small-cap healthcare name back above its 50-day average of A$0.00917. We examine valuation, liquidity, sector context and what the Meyka AI forecast implies for near-term risk and reward.

Pre-market price action: 1ST.AX stock

1ST Group Limited (1ST.AX) opened the ASX pre-market at A$0.011, up A$0.002 from the previous close of A$0.009. Volume surged to 2,075,140 versus an average volume of 678,621, producing a relative volume of 3.06. The intraday range was narrow, Day Low A$0.011 and Day High A$0.011, suggesting concentrated buying interest. Higher trading activity explains the 22.22% one-day move and signals short-term momentum for traders.

Key financials and valuation: 1ST.AX stock

1ST Group has a market cap of A$15,586,889.00 and 1,416,989,952 shares outstanding. Trailing EPS is -0.01 and reported PE is -1.10, reflecting negative earnings. Price-to-sales is 3.49 and price averages show 50-day A$0.00917 and 200-day A$0.00796. Liquidity metrics are mixed: current ratio 0.83 and cash per share A$0.00110. These figures show a microcap with stretched balance-sheet metrics and limited cash buffers.

Meyka grade and forecast: 1ST.AX stock

Meyka AI rates 1ST.AX with a score out of 100. The platform assigns a score 61.39 (Grade B) and suggests HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics and analyst-style forecasts. Meyka AI’s forecast model projects a yearly price of A$0.00718, versus the current price A$0.011, an implied downside of -34.75%. Forecasts are model-based projections and not guarantees.

Technical and sector context: 1ST.AX stock

Technically, 1ST.AX is trading above its 50-day and 200-day averages, which can attract short-term momentum traders. The stock’s Year High A$0.015 and Year Low A$0.004 place the current price near the lower half of the range. In the ASX Healthcare sector, the average one-year performance is +4.39% and average PE is 33.69. 1ST.AX is a small healthcare information services name and is outperforming many small peers on a six-month basis, but it remains volatile.

Risks and catalysts: 1ST.AX stock

Key risks include continued negative EPS, thin market cap, and a current ratio below 1.00. Working capital is negative and interest coverage is weak. Catalysts would be contract wins for GoBookings.com, adoption gains at MyHealth1st.com.au, telehealth rollouts or government tenders. Retail-driven volume spikes can reverse quickly; risk management is essential for traders.

Price targets and trading idea: 1ST.AX stock

Near-term support sits at the year low A$0.004 and immediate resistance at the year high A$0.015. Scenario price targets for traders: conservative A$0.006, base-case A$0.015, bullish A$0.025. These are illustrative trading levels, not firm analyst ratings. Use tight stop-losses and position sizes suitable for microcap volatility. See live market context on CNBC and company background at the 1ST Group site and our Meyka 1ST.AX page.

Final Thoughts

1ST Group (1ST.AX) delivered a strong pre-market pop on 05 Feb 2026, rising 22.22% to A$0.011 on a 2,075,140 share volume surge. The move puts the stock above its 50-day and 200-day averages, but fundamentals remain stretched. Meyka AI’s model projects a yearly price of A$0.00718, implying -34.75% downside versus today’s price. Meyka AI rates 1ST.AX with a score out of 100 at 61.39 (B, HOLD), a view that balances sector opportunity in healthcare services against weak earnings and liquidity constraints. Traders should treat the pre-market gain as a momentum signal, not a validation of fundamentals. For investors, catalyst-based upside would need clearer revenue growth or contract wins to justify a re-rating toward the A$0.015 base-case target. Forecasts are model-based and not guarantees; we recommend close monitoring of trading volume, any company announcements, and broader ASX market direction before adjusting positions.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.